Myopic Choroidal Neovascularization-Reference-Cited by-同舟云学术

Myopic Choroidal Neovascularization

Published:2011-12 Issue:12 Volume:118 Page:2521-2523
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Ruiz-Moreno Jose M.,López-Gálvez María I.,Donate Juan,Gomez-Ulla Francisco,García-Arumí José,García-Layana Alfredo,Sellés Inmaculada,Reche Juan,Montero Javier A.,Pazos Belen,Zapata Miguel A.,Pastor José C.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference5 articles.

1. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin;Ophthalmology,2001

2. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization;Tong;Am J Ophthalmol,2006

3. Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy;Hayashi;Am J Ophthalmol,2009

4. Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization;Ruiz-Moreno;Retina,2010

5. Intravitreal bevacizumab to treat myopic choroidal neovascularization: 2-year outcome;Ruiz-Moreno;Graefes Arch Clin Exp Ophthalmol,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of myopic choroidal neovascularization: a network meta-analysis and review;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-11-11

2. Targeting choroidal vasculopathy via up-regulation of tRNA-derived fragment tRF-22 expression for controlling progression of myopia;Journal of Translational Medicine;2023-06-24

3. Characteristics of Recurrence in Patients with Polypoidal Choroidal Vasculopathy and Myopic Choroidal Neovascularization;Journal of Retina;2019-05-31

4. Myopic maculopathy: Current status and proposal for a new classification and grading system (ATN);Progress in Retinal and Eye Research;2019-03

5. Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization;Scientific Reports;2018-09-26